Fall 2009
Cancer Center Seminar Series
Fall 2009 Schedule
Fridays 12:30-1:30pm
McKim Hall Auditorium, unless otherwise noted
The UVA Cancer Center presents this seminar series. Refreshments will be served outside McKim Auditorium beginning at 12:00.
Please note, the Seminar Series is not being offered for CME credit.
August September October November December
|
Aug 7, 2009 |
Seminar will be in Jordan 1-17 John H. Sampson, M.D., Ph.D., Duke University Medical Center, Department of Surgery/Neurosurgery, Durham, N.C. Advancing Tumor-specific Immunotherapy to the Holy Grail of Big Pharma and Beyond...! |
Host: Roger
Abounader, M.D., Ph.D., |
Jordan 1-17 |
|
|
|||
| Sept 18, 2009 |
Deborah Lannigan, Ph.D., Associate
Professor, Department of Microbiology and Center for Cell
Signaling High RSK is High Risk for Cancer? |
Host: Sally Parsons, Ph.D., Dept of
Microbiology |
McKim Aud |
|
|
|||
| Sept 25, 2009 | Ronald C. Hendrickson, Ph.D., Head of
Proteomics, Molecular Profiling, Merck Research Laboratories, Rahway,
NJ Proteomics: An Integral Part of Merck's Strategy for Biomarker Discovery and New Target Identification |
Host: Don Hunt, Ph.D., Depts of Chemistry
& Pathology |
McKim Aud |
|
|
|||
| Oct 2, 2009 |
Anindya Dutta, M.D., Ph.D., Professor,
Departmentst of Biochemistry & Molecular Genetics and
Pathology Ultra-Highthroughput Sequencing of RNA or DNA in Cancer Biology |
Host: Sally Parsons, Ph.D., Dept of
Microbiology |
McKim Aud |
|
|
|||
| Oct 9, 2009 |
John H. Bushweller, Ph.D., Professor of
Molecular Physiology and Biological Physics, Professor of
Chemistry Structural and Chemical Biology Approaches to Understanding and Treating Leukemia |
Host: Sally Parsons, Ph.D., Dept of
Microbiology |
McKim Aud |
|
|
|||
| Oct 16, 2009 | Joyce L. Hamlin, Ph.D., Professor and
Chair, Department of Biochemistry & Molecular Genetics Regulating and Disregulating Origins of Replication in Normal and Tumor Cells |
Host: Sally Parsons, Ph.D., Dept of
Microbiology |
McKim Aud |
|
|
|||
| Oct 23, 2009 |
Mien-Chie Hung, Ph.D., Professor and
Chairman of Molecular and Cellular Oncology, Director, Breast Cancer
Basic Research Program, University of Texas MD Anderson Cancer Center,
Houston, TX To Believe or Not to Believe: Novel Functions of EGF Receptor |
Host: Sally Parsons, Ph.D., Dept of
Microbiology |
McKim Aud |
|
|
|||
| Oct 30, 2009 | Amy P. Abernethy, M.D., Program
Director, Duke Cancer Care Research Program, Cancer Control Program
Associate Director, Duke Comprehensive Cancer Center, Medical Director,
Oncology Quality, Outcomes, and Patient-centered Care, Duke University
Health System Cancer Symptom Management: A Systematic Approach to Evidence Development and Implementation |
Host: Paul Read, M.D., Ph.D., Dept of Rad Onc | McKim Aud |
|
|
|||
| Nov 6, 2009 |
Sylvia Adams, M.D., Assistant Professor
of Medicine, Langone Medical Center, New York University, New York,
NY Clinical investigation of Dendritic Cells, Montanide and Toll-like Receptor Agonists as Cancer Vaccine Adjuvants |
Host: David Mullins, Ph.D., Dept of Microbiology | McKim Aud |
|
|
|||
| Nov 13, 2009 | Jordan 1-17, 12:15-1:15 Craig L. Slingluff, Jr., M.D., Professor, Department of Surgical Oncology, Vice-Chair for Research, Director, Human Immune Therapy Center Immunologic and Regulatory Effects of Cancer Vaccine Adjuvants Systemically and at the Vaccine Site |
Host: Sally Parsons, Ph.D., Dept of
Microbiology |
Jordan 1-17 |
|
|
|||
| Nov 20, 2009 | Jedd D. Wolchok, M.D., Ph.D, Melanoma
Sarcoma Oncology, Memorial Sloan-Kettering Cancer Center Clinical and Correlative Immunologic Results of CTLA-4 Blockade in Melanoma |
Host: Tim Bullock, Ph.D., Dept of
Pathology |
McKim Aud |
|
|
|||
| Dec 4, 2009 | David L. Brautigan, Ph.D., Professor of
Microbiology and Internal Medicine, Director, Center for Cell
Signaling Ancient Protein Phosphatase Regulation of Centrosomes, Chromosomes, and Cilia |
Host: Sally Parsons, Ph.D., Dept of
Microbiology |
McKim Aud |
|
|
|||
| Dec 11, 2009 |
Sarah E. Aiyar, Ph.D., Instructor,
Department of Medicine, Endocrinology and Metabolism Combination Therapy for Treatment of Metastatic Breast Cancer |
Host: Peggy Shupnik, Ph.D., Dept of
Medicine |
McKim Aud |
|
|
|||
| Dec 18, 2009 |
Michael Douvas, M.D., Disivion of
Hematology/Oncology and Fellow, Mark Prichard, M.D., Division of
Hematology/Oncology Therapeutic Implications of Variant Philadelphia Chromosome Translocations in CML and ALL |
Host: Sally Parsons, Ph.D., Dept of Microbiology | McKim Aud |
|
|
|||
